Astra's Farxiga results may open up type 1 diabetes opportunity

Astra's Farxiga results may open up type 1 diabetes opportunity

FRANKFURT (Reuters) - AstraZeneca's Farxiga was shown to help type-1 diabetics when added to standard insulin therapy, possibly opening up a additional market opportunity for the type-2 diabetes drug, the British drugmaker said in a statement on Thursday.

Read more...
Positive 0 LOL 0 Interesting 0 Sad 0 Revolting 0 Fake 0

Whoops, looks like something went wrong.